RegenETP, Inc.
Not enough financial coverage to compute a composite score for RGTPQ. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Companywww.polarityte.com
RegenETP, Inc. , a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services.
- CEO
- Richard Hague
- IPO
- 1999
- Employees
- 42
- HQ
- Salt Lake City, UT, US
Price Chart
Performance & Tape
- 52W High
- $0.22
- 52W Low
- $0.00
- 50D MA
- $0.15
- 200D MA
- $0.12
- Beta
- 2.91
- Avg Volume
- 3.13K
Get TickerSpark's AI analysis on RGTPQ
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our RGTPQ Coverage
We haven't published any research on RGTPQ yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate RGTPQ Report →